1. Home
  2. RUSHB vs IMVT Comparison

RUSHB vs IMVT Comparison

Compare RUSHB & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rush Enterprises Inc. Class B

RUSHB

Rush Enterprises Inc. Class B

N/A

Current Price

$64.17

Market Cap

5.1B

ML Signal

N/A

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$34.12

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUSHB
IMVT
Founded
1965
2018
Country
United States
United States
Employees
7355
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RUSHB
IMVT
Price
$64.17
$34.12
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$33.00
AVG Volume (30 Days)
62.4K
2.2M
Earning Date
04-28-2026
05-28-2026
Dividend Yield
1.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.44
N/A
P/E Ratio
$16.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.71
$13.79
52 Week High
$79.13
$36.29

Technical Indicators

Market Signals
Indicator
RUSHB
IMVT
Relative Strength Index (RSI) 40.04 66.22
Support Level $62.93 $22.84
Resistance Level $64.75 N/A
Average True Range (ATR) 2.03 1.89
MACD -0.46 0.60
Stochastic Oscillator 20.94 79.07

Price Performance

Historical Comparison
RUSHB
IMVT

About RUSHB Rush Enterprises Inc. Class B

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: